Pfizer CEO Albert Bourla (Evan Vucci, AP Images)

Pfiz­er opens doors at newest gene ther­a­py site in NC as part of $800M push in­to next-gen drugs

The Covid-19 pan­dem­ic has been an ex­treme­ly prof­itable time for Pfiz­er, and the mas­sive drug­mak­er is us­ing that lever­age to ad­vance its port­fo­lio writ large. Now, Pfiz­er’s emerg­ing gene ther­a­py biz will have some new el­bow room as it con­tin­ues to grow in the com­ing years.

Pfiz­er this week opened a $68.5 mil­lion gene ther­a­py man­u­fac­tur­ing fa­cil­i­ty in Durham, North Car­oli­na, as part of a mul­ti-year, $800 mil­lion plan to out­fit its next-gen ther­a­peu­tics busi­ness, the com­pa­ny said Wednes­day.

Endpoints News

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters